| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
27,199.50
|
|
Change (%)
|
301.40 (1.12%)
|
|
Best Buy (RS)
|
27196.3(x4)
|
|
Best Sell (RS)
|
27271.6(x1)
|
|
Today's Range (RS)
|
26,961.10
-
27,949.95
|
|
52-Week Range (RS)
|
25,164.00
-
35,921.55
|
|
Beta (1 Year)
|
0.31
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap |
| News |
|
Corporate Details |
| Abbott India to convene AGM |
| Board of Abbott India recommends final dividend |
| Board of Abbott India recommends special dividend |
| Abbott India standalone net profit rises 7.60% in the March 2026 quarter |
| Abbott India clocks PAT of Rs 394.93 crore in March'26 quarter |
| Abbott India to discuss results |
| Abbott India standalone net profit rises 4.21% in the December 2025 quarter |
| Abbott India Q3 PAT jumps 4% YoY to Rs 376 cr |
| Abbott India to announce Quarterly Result |
| Volumes soar at Abbott India Ltd counter |
|
|
|
| Incoporation Year : 1944 |
| Chairman : Munir Shaikh |
| Ownership Group : MNC Asc-Abbott |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Abbott India Ltd
Unit No 3 Corporate Park,
Sion Trombay Road Chembur,
Mumbai,
Maharashtra-400071 |
Phone:91-22-67978888/50461000/2000/1119
Fax:91-22-50169400 |
| E-Mail : investorrelations.india@abbott.com; webmaster@abbo |
| URL : http://www.abbott.co.in |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
05-May-2026 |
25323.50 |
6.22 |
| 1Month |
13-Apr-2026 |
25725.85 |
4.56 |
| 3Month |
12-Feb-2026 |
26684.90 |
0.80 |
| 6Month |
12-Nov-2025 |
29562.45 |
-9.01 |
| 1Year |
12-May-2025 |
30042.95 |
-10.47 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Large & Midcap Fund |
2.04 |
783.40 |
| AXIS Midcap Fund |
1.28 |
414.20 |
| Canara Robeco Large and Mid Cap Fund |
1.43 |
352.51 |
| Nippon India Multi Cap Fund |
0.58 |
305.10 |
| Nippon India Pharma Fund |
2.26 |
188.69 |
|
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Glaxosmithkline Pharmaceuticals Ltd |
2,462.80 |
0.60 |
3,515.95 |
2,218.00 |
41,472.29 |
| Pfizer Ltd |
4,640.00 |
-1.88 |
5,987.65 |
4,238.90 |
21,633.64 |
| Astrazeneca Pharma India Ltd |
8,350.05 |
0.50 |
10,653.05 |
7,630.00 |
20,770.75 |
| Sanofi Consumer Healthcare India Ltd |
4,603.90 |
0.56 |
5,954.00 |
3,950.50 |
10,543.65 |
| Procter & Gamble Health Ltd |
5,215.50 |
2.21 |
6,700.00 |
4,699.70 |
8,470.58 |
|
|
|
|